Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Gut Microbes. 2014 Mar-Apr;5(2):146-51. doi: 10.4161/gmic.27651. Epub 2014 Jan 22.

PMID:
24637606
[PubMed - in process]
2.

Faecalibacterium prausnitzii and human intestinal health.

Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P.

Curr Opin Microbiol. 2013 Jun;16(3):255-61. doi: 10.1016/j.mib.2013.06.003. Epub 2013 Jul 3. Review.

PMID:
23831042
[PubMed - indexed for MEDLINE]
3.

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P.

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6. doi: 10.1073/pnas.0804812105. Epub 2008 Oct 20.

PMID:
18936492
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Differential Modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of Host Peripheral Lipid Metabolism and Histone Acetylation in Mouse Gut Organoids.

Lukovac S, Belzer C, Pellis L, Keijser BJ, de Vos WM, Montijn RC, Roeselers G.

MBio. 2014 Aug 12;5(4). pii: e01438-14. doi: 10.1128/mBio.01438-14.

PMID:
25118238
[PubMed - in process]
Free PMC Article
5.

Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air.

Khan MT, van Dijl JM, Harmsen HJ.

PLoS One. 2014 May 5;9(5):e96097. doi: 10.1371/journal.pone.0096097. eCollection 2014.

PMID:
24798051
[PubMed - in process]
Free PMC Article
6.

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.

Martín R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermúdez-Humarán LG, Langella P.

Inflamm Bowel Dis. 2014 Mar;20(3):417-30. doi: 10.1097/01.MIB.0000440815.76627.64.

PMID:
24418903
[PubMed - in process]
7.

Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.

Wrzosek L, Miquel S, Noordine ML, Bouet S, Joncquel Chevalier-Curt M, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C, Langella P, Thomas M.

BMC Biol. 2013 May 21;11:61. doi: 10.1186/1741-7007-11-61.

PMID:
23692866
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Live Faecalibacterium prausnitzii in an apical anaerobic model of the intestinal epithelial barrier.

Ulluwishewa D, Anderson RC, Young W, McNabb WC, van Baarlen P, Moughan PJ, Wells JM, Roy NC.

Cell Microbiol. 2014 Sep 16. doi: 10.1111/cmi.12360. [Epub ahead of print]

PMID:
25224879
[PubMed - as supplied by publisher]
9.

How can Faecalibacterium prausnitzii employ riboflavin for extracellular electron transfer?

Khan MT, Browne WR, van Dijl JM, Harmsen HJ.

Antioxid Redox Signal. 2012 Nov 15;17(10):1433-40. doi: 10.1089/ars.2012.4701. Epub 2012 Jun 25.

PMID:
22607129
[PubMed - indexed for MEDLINE]
10.

Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.

Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S, Fujiyama Y, Andoh A.

J Gastroenterol Hepatol. 2013 Apr;28(4):613-9. doi: 10.1111/jgh.12073.

PMID:
23216550
[PubMed - indexed for MEDLINE]
11.

Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.

Qiu X, Zhang M, Yang X, Hong N, Yu C.

J Crohns Colitis. 2013 Dec 1;7(11):e558-68. doi: 10.1016/j.crohns.2013.04.002. Epub 2013 May 2.

PMID:
23643066
[PubMed - indexed for MEDLINE]
12.

The dual role of MAPK pathway in the regulation of intestinal barrier: the role of the commensal bacterium Faecalibacterium prausnitzii on this regulation.

Martin R, Lenoir M, Chain F, Langella P, Bermúdez-Humarán LG.

Inflamm Bowel Dis. 2014 Jul;20(7):E17-8. doi: 10.1097/MIB.0000000000000070. No abstract available.

PMID:
24859300
[PubMed - in process]
13.

Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature.

Cao Y, Shen J, Ran ZH.

Gastroenterol Res Pract. 2014;2014:872725. doi: 10.1155/2014/872725. Epub 2014 Mar 27. Review.

PMID:
24799893
[PubMed]
Free PMC Article
14.

Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth.

Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJ, Garcia-Gil LJ, Flint HJ.

Appl Environ Microbiol. 2012 Jan;78(2):420-8. doi: 10.1128/AEM.06858-11. Epub 2011 Nov 18.

PMID:
22101049
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Specificity comparison of three Feacalibacterium prausnitzii-specific PCR primer pairs].

Feng J, Hua W, Zhao L, Zhao Y, Shen J.

Wei Sheng Wu Xue Bao. 2011 Jun;51(6):819-27. Chinese.

PMID:
21866708
[PubMed - indexed for MEDLINE]
16.

Quantification of Faecalibacterium prausnitzii- and Subdoligranulum variabile-like bacteria in the cecum of chickens by real-time PCR.

Lund M, Bjerrum L, Pedersen K.

Poult Sci. 2010 Jun;89(6):1217-24. doi: 10.3382/ps.2010-00653.

PMID:
20460669
[PubMed - indexed for MEDLINE]
17.

Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.

Lopez-Siles M, Martinez-Medina M, Busquets D, Sabat-Mir M, Duncan SH, Flint HJ, Aldeguer X, Garcia-Gil LJ.

Int J Med Microbiol. 2014 May;304(3-4):464-75. doi: 10.1016/j.ijmm.2014.02.009. Epub 2014 Feb 21.

PMID:
24713205
[PubMed - in process]
18.

Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?

Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Hunter JO, Cole JA.

FEMS Microbiol Lett. 2010 Sep 1;310(2):138-44. doi: 10.1111/j.1574-6968.2010.02057.x. Epub 2010 Jul 8.

PMID:
20695899
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Functional Metabolic Map of Faecalibacterium prausnitzii, a Beneficial Human Gut Microbe.

Heinken A, Khan MT, Paglia G, Rodionov DA, Harmsen HJ, Thiele I.

J Bacteriol. 2014 Sep 15;196(18):3289-302. doi: 10.1128/JB.01780-14. Epub 2014 Jul 7.

PMID:
25002542
[PubMed - in process]
20.

The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults.

Feng J, Tang H, Li M, Pang X, Wang L, Zhang M, Zhao Y, Zhang X, Shen J.

Arch Microbiol. 2014 Jan;196(1):73-7. doi: 10.1007/s00203-013-0942-2. Epub 2013 Nov 30.

PMID:
24292154
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk